Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
about
Auto immune hepatitisStatins and its hepatic effects: Newer data, implications, and changing recommendationsStatin Therapy: Review of Safety and Potential Side EffectsCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewAutoimmune-like drug-induced liver injury: a review and update for the clinician.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Chronic liver injury induced by drugs: a systematic review.Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessmentGGPP-Mediated Protein Geranylgeranylation in Oocyte Is Essential for the Establishment of Oocyte-Granulosa Cell Communication and Primary-Secondary Follicle Transition in Mouse Ovary.Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled TrialRationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy.Drug-induced liver injury: Do we know everything?Statins and delirium: is there a role?Statins and Cataracts--a visual insight.Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.Statins for aortic valve stenosis.Hepatotoxicity of statins and other lipid-lowering agents.The histopathological evaluation of drug-induced liver injury.Rationale for the use of statins in liver disease.Drug-induced Liver Injury: The Hepatic Pathologist's Approach.Statin-induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis.Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.Statins Reduce the Risk of Cirrhosis and its Decompensation in CHB Patients?Prevalence and risk factors of coronary artery disease in patients with chronic viral hepatitis.Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity.Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.Recurrence and Severe Worsening of Hepatotoxicity After Reintroduction of Atorvastatin in Combination With Ezetimibe.Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?Nonhuman Primates and Translational Research-Cardiovascular Disease.Identification and Characterization of Fenofibrate-Induced Liver Injury.Statin Prescribing in the Elderly: Special Considerations.Histopathological challenges in suspected drug-induced liver injury.Natural history and outcomes in drug-induced autoimmune hepatitis.Effect of Stains on LDL Reduction and Liver Safety: A Systematic Review and Meta-Analysis.Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.Prescribing a statin to a cirrhotic patient to reduce hepatic decompensation and improve survival: impossible you say?
P2860
Q26746242-A99085B1-A507-4DCF-8319-FBAE18F5EDAEQ26767065-4CF884F5-65AC-4315-BFED-8AA9E7B6A1F3Q28072883-FB2E97AD-3851-43C3-8E89-2AF9ACD24A73Q28076346-AF05BE40-61DF-459C-99CF-408302079673Q30276377-52E3A646-1307-4298-93D2-02A4F2E0DB74Q30277969-F635B5E7-A15E-4B44-B8A2-2478F950CD40Q30278737-1E5CC957-86B4-42D5-8A8C-4CAAAF9D0E74Q35819331-DBBF0C3D-3908-4856-99A9-34542E92FBA9Q35992231-AA4A0085-9445-4078-AF61-86FFF2B47A05Q36245452-40F14F04-B4C1-4E45-9CBD-0D168F0836ACQ36497872-E4D28D5C-FCB9-4A0B-A637-2B3ED60489D0Q37385899-EA117104-0E82-4834-BBE6-F34FF18324DBQ37748005-FCBBBE8A-CE6B-4F6F-810E-12CD3142CA1CQ38268343-3891CA4E-AAD4-4A93-9AF3-996BADAD37FFQ38285483-5BEE123C-CFC6-4210-BBB5-A20750074640Q38524991-9F5BFE98-C340-42D7-B41C-FD1029F36254Q38741861-77F81899-D211-4E41-BF1C-D8EC484BAEEEQ38890066-10700359-803A-40A8-A327-A2B46D521A27Q38946280-625A2104-1753-4EB7-9C81-5D325138EF80Q39012464-AEE18592-E40A-4756-BBF4-88EB7D7F8056Q39037640-4F594BEC-928A-4C7C-984D-2E025397931EQ39171942-230BE11A-3208-47DE-8602-1232C9A84449Q39307576-822E3336-D27D-4D25-A6F3-8F733302B819Q39752811-947D2ABB-0F15-4044-876A-3F0FCE75EBEDQ39861096-4E105A68-CC5D-4DC8-BBFF-DE0F9A80D644Q40347988-A89B0726-6004-4DD9-B755-DE8C50E1C511Q40966429-C1984D28-F0FE-493C-A193-ACCF3BC31AA8Q41528115-E6B88471-2A4C-48F0-ABFB-765207AF831AQ41919194-7F6BA9C1-DA76-4A47-B3B7-73643DA7D3A9Q42266154-84B7A5C0-E828-429C-86D0-62A6706287A0Q42365140-AE2AC695-EFE8-4750-9CCD-F9CC7997DB14Q46131886-E650F628-E406-4623-842B-34223E8537BDQ46292627-63D5E074-E1DE-434E-9BD5-F83E92928AB9Q47422605-19002CE0-19E5-44E8-A594-58CA2751E5C6Q47567439-F3FC9936-DBD7-4D67-A157-3B1AA303D4EEQ48136372-046C2366-97E0-4180-BA66-ABC4E6EA05FCQ51027472-258D0CFE-3E1D-48E6-8E9E-26E544F34CAFQ52564491-30072F4E-703B-4863-804F-C55CF55F9B76Q52688656-E3F0EC0B-BF63-4299-8195-134E5ACFE8BFQ55058377-AF402EB5-E327-4B89-98BF-D4AAA101FADE
P2860
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@ast
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@en
type
label
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@ast
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@en
prefLabel
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@ast
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@en
P2093
P2860
P356
P1433
P1476
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network
@en
P2093
Herbert L Bonkovsky
Huiman Barnhart
Jay H Hoofnagle
Jiezhun Gu
Mark W Russo
Naga Chalasani
Robert J Fontana
P2860
P304
P356
10.1002/HEP.27157
P407
P577
2014-05-13T00:00:00Z